2016
DOI: 10.1016/j.ghir.2016.02.002
View full text | Cite
|
Sign up to set email alerts
|

Abstract: Reduced somatotropic [growth hormone (GH) and insulin-like growth factor-1 (IGF-1)] action has been associated with delayed and slower aging, reduced risk of frailty, reduced age-related disease and functional decline, and with remarkably extended longevity. Recent studies have added to the evidence that these relationships discovered in laboratory populations of mice apply to other mammalian species. However, the relationship of the somatotropic signaling to human aging is less striking, complex and controver… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
40
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 47 publications
(40 citation statements)
references
References 79 publications
(114 reference statements)
0
40
0
Order By: Relevance
“…The reports of remarkably low cancer incidence and progression in the GHRKO mouse (97) as well as in LS individuals (14,102,103) coupled with human epidemiological studies reporting an increased risk for specific cancers (colorectal, thyroid) in patients with acromegaly (100,101,102,103,104,105,106,107,108,109,110,111) collectively offer an indication of the anti-cancer effects of attenuating GH-action. In GH treated patients with childhood-or adult-onset GHD, no association of GH treatment and development of primary cancer was found, based on available data (112,113).…”
Section: Cancermentioning
confidence: 99%
See 2 more Smart Citations
“…The reports of remarkably low cancer incidence and progression in the GHRKO mouse (97) as well as in LS individuals (14,102,103) coupled with human epidemiological studies reporting an increased risk for specific cancers (colorectal, thyroid) in patients with acromegaly (100,101,102,103,104,105,106,107,108,109,110,111) collectively offer an indication of the anti-cancer effects of attenuating GH-action. In GH treated patients with childhood-or adult-onset GHD, no association of GH treatment and development of primary cancer was found, based on available data (112,113).…”
Section: Cancermentioning
confidence: 99%
“…Additional factors that lead to the GHRKO mice being the longest-lived mouse in the world include the following -(i) increased stress resistance resulting from superior redox homeostasis due to upregulated expression and activity of glutaredoxin and thioredoxin detoxification systems (214,215,216,217) rather than changes in free-radical scavenging(218), (ii) reduced activity of TORC1 kinase complex (219, 220, 221), (iii) resistance to neoplastic incidence and growth(24, 97), (iv) suppressed hypothalamic inflammation(222) -an end-goal of anti-ageing drugs(223), (v) an anti-inflammatory adipokine profile, inverted liver-WAT lipid distribution and reduced senescent cell burden in WAT(62, 68, 70, 72), (vi) increased markers of mitochondrial biogenesis including higher levels of AMPK, SIRT1, and SIRT3 in heart and increased eNOS and PGC1α levels in skeletal muscle and kidney (224), (vii) detrimental effects of GH/IGF axis on very small embryonic-like stem cell pools in adult tissues (225,226) where age-related changes in DNA methylation patterns lead to increased sensitivity to circulating GH, IGF-1 and insulin with age with concomitant depletion of stem-cell pool and impaired tissue regeneration(225), (viii) resistance to diabetogenic effects of a HF diet (14), and (ix) improved insulin sensitivity(15).…”
Section: Factors For Extended Lifespan Of Ghrko Micementioning
confidence: 99%
See 1 more Smart Citation
“…In addition to the direct effects of HGH on human metabolism, it is of utmost importance to emphasize that an association also exists between HGH activity and IGF-1 [2,4] because IGF-1 production is generally dependent on HGH in what is termed the HGH/IGF-1 somatotropic axis [10]. Thus, this aptly named HGH/IGF-1 paracrine axis constitutes a positive feedback loop for determining the level of HGH biological activity.…”
Section: Journal Of Steroids and Hormonal Sciencementioning
confidence: 99%
“…Moreover, in healthy individuals, the level of spontaneous as well as stimulated HGH secretion are significantly decreased with advanced aging [9]. However, these findings must now be re-evaluated in view of more recent findings reported by Bartke et al [10] who showed that reduced levels of HGH and insulin-like growth factor-1 (IGF-1) activity are associated with delayed or a "slower" rate of aging. Thus, a lower level of HGH was correlated with a reduction in frailty, age-related diseases and a decline in functional status, BUT most critically, in an extension of longevity.…”
mentioning
confidence: 96%